AJP - Renal Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (June 1, 2004). doi:10.1152/ajprenal.00278.2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/4/F806    most recent
00278.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brond, L.
Right arrow Articles by Jonassen, T. E.N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brond, L.
Right arrow Articles by Jonassen, T. E.N.
Submitted on August 7, 2003
Accepted on May 26, 2004

Uncoupling of vasopressin signaling in collecting ducts from rats with CBL induced liver cirrhosis

Lone Brond1, Niels Hadrup1, Nanna Salling1, Malene Torp1, Martin Graebe1, Sten Christensen1, Soren Nielsen2, and Thomas E.N. Jonassen1*

1 Department of Pharmacology, University of Copenhagen, Copenhagen, Denmark
2 The Water and Salt Research Center, University of Aarhus, Aarhus, Denmark

* To whom correspondence should be addressed. E-mail: fitj{at}farmakol.ku.dk.

Vasopressin (AVP) stimulates collecting duct water reabsorption through cAMP mediated membrane targeting and increased expression of the aquaporin 2 (AQP2) water channel. Rats with liver cirrhosis induced by common bile duct ligation (CBL) show decreased protein expression of AQP2 despite increased plasma concentrations of AVP. The present study was conducted to investigate possible mechanisms behind this uncoupling of AVP signaling. The rats were examined four weeks after CBL or Sham-operation. The CBL rats had increased plasma AVP concentrations (CBL: 3.2±0.2 vs. Sham: 1.4±0.4 pg/mL, p<0.05) and reduced AQP2 (0.62±0.11%) and phosphorylated AQP2 (0.50±0.06%) protein expression when compared to Sham. However, examination of subcellular AQP2 localization by immunohistochemistry showed unchanged plasma membrane targeting in CBL rats indicating a sustained ability of AQP2 shortterm regulation. In a separate series of animals thirsting was found to normalize AQP2 expression, indicating that AVP uncoupling in CBL rats is a physiological compensatory mechanism aimed at avoiding dilutional hyponatremia. Studies on microdissected collecting ducts from CBL rats showed decreased cAMP accumulation in response to AVP stimulation. The presence of the non-specific phosphodiesterase inhibitor IBMX normalized the cAMP accumulation, indicating that cAMP-phosphodiesterase activity is increased in CBL rats. However, in contrast to this Western blotting showed a decreased expression of several phosphodiesterase splice variants. We conclude that CBL rats develop an escape from AVP to prevent the formation of dilutional hyponatremia in response to increased plasma AVP concentrations. The mechanism behind AVPescape seems to involve decreased collecting duct sensitivity to AVP as a result of increased cAMP-phosphodiesterase activity.




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
R. A. Fenton, L. Brond, S. Nielsen, and J. Praetorius
Cellular and subcellular distribution of the type-2 vasopressin receptor in the kidney
Am J Physiol Renal Physiol, September 1, 2007; 293(3): F748 - F760.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.